1. Home
  2. DERM vs IGA Comparison

DERM vs IGA Comparison

Compare DERM & IGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

SELL

Current Price

$4.30

Market Cap

190.3M

Sector

Health Care

ML Signal

SELL

Logo Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest

IGA

Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest

SELL

Current Price

$10.00

Market Cap

162.0M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
DERM
IGA
Founded
2014
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
190.3M
162.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DERM
IGA
Price
$4.30
$10.00
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $13.75
N/A
AVG Volume (30 Days)
★ 193.9K
45.4K
Earning Date
11-16-2026
01-01-0001
Dividend Yield
N/A
★ 8.93%
EPS Growth
★ 34.72
N/A
EPS
N/A
★ N/A
Revenue
★ $61,858,000.00
N/A
Revenue This Year
$25.29
N/A
Revenue Next Year
$50.00
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 10.20
N/A
52 Week Low
$4.31
$9.21
52 Week High
$9.56
$10.77

Technical Indicators

Market Signals
Indicator
DERM
IGA
Relative Strength Index (RSI) 36.54 56.77
Support Level $4.31 $10.08
Resistance Level $5.50 $10.76
Average True Range (ATR) 0.33 0.18
MACD 0.02 0.03
Stochastic Oscillator 18.50 94.30

Price Performance

Historical Comparison
DERM
IGA

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

About IGA Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest

Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategies.

Share on Social Networks: